Skip to content

Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania

Correlation of Audiovisual Features With Clinical Variables and Neurocognitive Functions in Bipolar Disorder, Mania

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03857438
Enrollment
89
Registered
2019-02-28
Start date
2016-09-30
Completion date
2017-07-08
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Affective Computing, Artificial Intelligence, Bipolar Disorder, Manic, Multi- Modal Analysis, Neurocognition, Treatment Resistant Disorders

Keywords

Bipolar and Related Disorders, Mood Disorders, Mental Disorders, Behavioral Symptoms, Cognitive functions, Simulation

Brief summary

The aim of this study is to show the physiological changes during manic episode in bipolar mania how much they differentiate from remission and healthy control. Relation of audio-visual features as physiological changes and cognitive functions and clinical variables will be searched. The aim is to find biologic markers for predictors of treatment response via machine learning techniques to be able to reduce treatment resistance and give an idea for personalized treatment of bipolar patients.

Detailed description

The objective of this research protocol is to find audio-visual features which differentiates bipolar mani/ remission/ health/ simulation and predicts treatment response earlier and detect neurocognitive changes during mania/ remission and difference from the healthy control. During hospitalization in every follow up day (0th- 3rd- 7th- 14th- 28th day) and after discharge on the 3rd month, presence of depressive and manic features for patients was evaluated using Young Mania Rating Scale(YMRS) and Montgamery- Asberg Depresyon Scale (MADRS). Audiovisual recording is done by a video camera in every follow up day for patients and for healthy controls which includes also depression and mania simulation. Cambridge Neurophysiological Assessment Battery (CANTAB) were administered to both groups( for patients both in the manic phase and in the remission) to assess neurocognitive functions.

Interventions

DRUGOngoing treatment for bipolar mania

Prescribed by the following doctor during hospitalization and after discharge

DIAGNOSTIC_TESTAudiovisual recording during guided presentation

Seven tasks such as explaining the reason to come to hospital/participate in the activity, describing happy and sad memories, counting up to thirty, explaining two emotion eliciting pictures

Sponsors

Namik Kemal University
CollaboratorOTHER
Bosphorus University
CollaboratorUNKNOWN
Istanbul Saglik Bilimleri University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* diagnosis of BD type I, manic episode according to DSM-5 \[10\] given by the following doctor, * being informed of the purpose of the study and having given signed consent before enrollment.

Exclusion criteria

* being younger than 18 years or older than 60 years, * showing low mental capacity during the interview * expression of hallucinations and disruptive behaviors during the interview, * presence of severe organic disease, * presence of any organic disease that may affect cognition * having less than five years of public education * diagnosis of substance or alcohol abuse in the last three months (except nicotine and caffeine) * presence of cerebrovascular disorder, head trauma with longer duration of loss of consciousness, severe hemorrhage and dementia, * having electroconvulsive therapy in the last one year. For the healthy control group, the following additional criteria were considered for exclusion * presence of family history of mood or psychotic disorder, * presence of psychiatric disorder during interview or in the past.

Design outcomes

Primary

MeasureTime frameDescription
Treatment responsefrom baseline until 3rd monthThe proportion of Young Mania Rating Scale(YMRS) score ( at baseline to 3rd- 7th- 14th- 28th day and 3rd month ( Baseline scale/ Follow-up day scale) YMRS score utilized rating scales to assess manic symptoms ranged between 0-76 1. Remission: Yt \<= 7 2. Hypomania: 7 \< Yt \< 20 3. Mania: Yt \>= 20.
Changes in visual featuresBaseline and 3rd monthFunctionals of appearance descriptors extracted from fine-tuned Deep Convolutional Neural Networks (DCNN), geometric features obtained using tracked facial landmarks (Unweighted Average Recall) Geometric frame level 23 geometric features and apperance descriptors 4096 dimensional features from the last convolutional layer of the FER fine-tuned CNN which are summarized via mean and range functionals over sub-clips and the decisions are voted at video level, an UAR performance is obtained. Feature vectors extracted from video is modelled using Partial Least Squares (PLS) regression and Extreme Learning Machines classifiers Unweighted Average Recall (UAR), which is mean of class-wise recall scores, is commonly used as performance measure, instead of accuracy, which can be misleading in the case of class-imbalance
Changes in audio featuresBaseline and 3rd monthFunctionals of acoustic features extracted via openSMILE tool (Unweighted Average Recall) Acoustic low level descriptors including prosody (energy, Fundamental Frequency - F0), voice quality features (jitter and shimmer), Mel Frequency Cepstral Coefficients, which are commonly used in many speech technologies from audio, we use the 76-dimensional standard feature set used in the INTERSPEECH 2010 paralinguistic challenge as baseline. The second is our proposed set of 10 functionals, Mean, standard deviation, curvature coefficient , slope and offset , minimum value and its relative position, maximum value and its relative position, and the range Feature vectors extracted from audio is modelled using Partial Least Squares (PLS) regression and Extreme Learning Machines classifiers.
in Stop Signal TestBaseline and 3rd month(milisecond) SST- Succesful Stop Ratio SST- go- Reaction Time SST- Stop Signal Delay SST- Stop Signal Reaction Time SST- Total Correct
Changes in Rapid Visual ProcessingBaseline and 3rd monthRVP A' (A prime) is the signal detection measure of sensitivity to the target, regardless of response tendency (range 0.00 to 1.00; bad to good). RVP B'' (B double prime) is the signal detection measure of the strength of trace required to elicit a response (range -1.00 to +1.00)
in Cambridge Gambling TaskBaseline and 3rd month(milisecond) CGT Quality of decision making CGT Deliberation time CGT Delay aversion CGT Overall proportion bet
Changes in Emotion Recognition TestBaseline and 3rd month(rate of emotion prediction) Percent and numbers correct/incorrect prediction

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026